News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,051 Results
Type
Article (39736)
Company Profile (254)
Press Release (658061)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204346)
Career Advice (2011)
Deals (35444)
Drug Delivery (95)
Drug Development (81121)
Employer Resources (172)
FDA (16181)
Job Trends (14872)
News (345474)
Policy (32560)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2554)
Accelerated approval (5)
Adcomms (21)
Allergies (82)
Alliances (49477)
ALS (87)
Alzheimer's disease (1367)
Antibody-drug conjugate (ADC) (116)
Approvals (16181)
Artificial intelligence (242)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11647)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (182)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (262)
Cancer (2089)
Cardiovascular disease (167)
Career advice (1676)
Career pathing (29)
CAR-T (144)
Cell therapy (404)
Cervical cancer (19)
Clinical research (65903)
Collaboration (798)
Compensation (508)
Complete response letters (19)
COVID-19 (2588)
CRISPR (37)
C-suite (223)
Cystic fibrosis (100)
Data (2052)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (256)
Diagnostics (6351)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86363)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112039)
Executive appointments (693)
FDA (17364)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (722)
Gene editing (100)
Generative AI (19)
Gene therapy (288)
GLP-1 (697)
Government (4407)
Grass and pollen (4)
Guidances (51)
Healthcare (18832)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (110)
Indications (26)
Infectious disease (2728)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (312)
IPO (16505)
IRA (40)
Job creations (3641)
Job search strategy (1424)
Kidney cancer (9)
Labor market (36)
Layoffs (461)
Leadership (16)
Legal (7910)
Liver cancer (72)
Lung cancer (302)
Lymphoma (140)
Machine learning (5)
Management (58)
Manufacturing (282)
MASH (62)
Medical device (13353)
Medtech (13358)
Mergers & acquisitions (19453)
Metabolic disorders (655)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1873)
NextGen: Class of 2025 (6527)
Non-profit (4480)
Northern California (2535)
Now hiring (38)
Obesity (353)
Opinion (203)
Ovarian cancer (74)
Pain (81)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57286)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20537)
Phase II (29022)
Phase III (21621)
Pipeline (1115)
Policy (130)
Postmarket research (2564)
Preclinical (8688)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (373)
Real estate (5919)
Recruiting (65)
Regulatory (22235)
Reports (46)
Research institute (2322)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (125)
Series B (82)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2180)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3582)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (28)
United States (22032)
Vaccines (668)
Venture capitalists (38)
Weight loss (229)
Women's health (34)
Worklife (15)
Date
Today (32)
Last 7 days (473)
Last 30 days (2367)
Last 365 days (32927)
2025 (9222)
2024 (35256)
2023 (40108)
2022 (51232)
2021 (55766)
2020 (54127)
2019 (46577)
2018 (35048)
2017 (32150)
2016 (31530)
2015 (37600)
2014 (31367)
2013 (26387)
2012 (28595)
2011 (29299)
2010 (27362)
Location
Africa (719)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37840)
Australia (6200)
California (5784)
Canada (1941)
China (490)
Colorado (254)
Connecticut (262)
Delaware (135)
Europe (81172)
Florida (860)
Georgia (202)
Idaho (57)
Illinois (513)
India (25)
Indiana (300)
Iowa (9)
Japan (149)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (860)
Massachusetts (4333)
Michigan (215)
Minnesota (380)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1659)
New Mexico (28)
New York (1650)
North Carolina (938)
North Dakota (7)
Northern California (2535)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1316)
Puerto Rico (11)
Rhode Island (30)
South America (1097)
South Carolina (20)
South Dakota (1)
Southern California (2180)
Tennessee (99)
Texas (862)
Utah (171)
Virginia (135)
Washington D.C. (59)
Washington State (531)
West Virginia (3)
Wisconsin (51)
698,051 Results for "excision biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Excision BioTherapeutics Announces Oral Presentation at the 5th Genome Editing Therapeutics Summit
December 4, 2024
·
1 min read
Biotech Bay
Excision BioTherapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Excision BioTherapeutics, Inc. today announced presentation of six abstracts at the ASGCT 2024 Annual Meeting, which is being held from May 7-11, 2024 in Baltimore, Maryland.
April 10, 2024
·
3 min read
Biotech Bay
Excision BioTherapeutics Announces Data from the Phase 1/2 Trial of EBT-101 in HIV And In Vivo Efficacy Data in Herpes Virus and Hepatitis B
Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure latent viral infectious diseases, summarized the novel presentation of multiple studies at this week’s American Society of Gene and Cell Therapy (ASGCT) meeting.
May 13, 2024
·
4 min read
Biotech Bay
Excision BioTherapeutics Announces Oral Presentation of HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24 2024
Excision BioTherapeutics, Inc. today announced that it will make an oral presentation on April 24, 2024, at CRISPRMED24, the first CRISPR Medicine Conference, which is being held from April 23-25 in Copenhagen, Denmark.
April 16, 2024
·
1 min read
Biotech Bay
Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting
Excision BioTherapeutics, Inc. (“Excision”, the “Company”) today announced that it will present positive data from its herpes simplex virus-1 keratitis program, EBT-104, as well as an overview of a next-generation AAV delivery vector, at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting taking place May 7-11, 2024 in Baltimore, Maryland.
April 22, 2024
·
8 min read
Press Releases
Excision BioTherapeutics Announces Oral Presentation at the 2024 International HBV Meeting
September 9, 2024
·
1 min read
Biotech Bay
Excision BioTherapeutics Announces Oral Presentation of Preclinical HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24, 2024
Excision BioTherapeutics, Inc. today announced that it will deliver an oral presentation highlighting new data from its herpes simplex virus-1 keratitis (HSV-1 Keratitis) program, EBT-104, at CRISPRMED24, the CRISPR Medicine Conference, which is being held from April 23-25 in Copenhagen, Denmark.
April 22, 2024
·
3 min read
Drug Development
Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study
Results from a Phase I study presented Friday at the ASGCT 2024 annual meeting showed that despite a good safety profile, Excision BioTherapeutics’ HIV gene editor failed to suppress viral activity.
May 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Excision BioTherapeutics Awarded a “Fierce 15” Biotech Company of 2024
August 5, 2024
·
3 min read
Biotech Bay
Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting
Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, announced that it will present positive data from its program for Hepatitis B virus at the American Society of Gene & Cell Therapy 2024 Annual Meeting taking place May 7-11, 2024 in Baltimore, Maryland.
April 22, 2024
·
2 min read
1 of 69,806
Next
